Navigation Links
Serum carcinoembryonic antigen level can reflect adrenal adenoma
Date:11/21/2007

The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance. The serum cortisol, dopamine and noradrenalin levels were elevated. Computed tomography detected a left adrenal mass measuring 3.5 cm -- 3.0 cm in diameter. Metaiodobenzylguanidine scintigraphy was negative. Unexpectedly, the serum carcinoembryonic antigen (CEA) level was elevated. Fluorodeoxyglucose positron emission tomography showed increased uptake in the adrenal tumor only, with a maximum standardized uptake value of 2.8. Selective venography and blood sampling revealed the concentrations of cortisol, catecholamines and carcinoembryonic antigen were significantly elevated in the drainage vein of the tumor. A diagnosis of carcinoembryonic antigen-producing benign adenoma was made. After preoperative management, Dr. Hori's group performed a combined lateral and anterior transperitoneal laparoscopic adrenectomy. The patient's vital signs remained stable during surgery. Histopathological examination revealed a benign adenoma. The cortisol, catecholamine and carcinoembryonic antigen levels normalized immediately after surgery.

Laparoscopic adrenectomy (LA) was first performed in 1992, and this safe and effective treatment is now used worldwide for the management of functioning and non-functioning adrenal tumors. The minimal skin incisions provide a sufficient surgical field, anastomosis and reconstruction are not required, hemostasis can be achieved using laparoscopic devices, and the resected tumor can be removed through the small skin incision. Many previous documents focused on LA have already described the advantages and shortcomings of the transperitoneal and retroperitoneal approaches. There are two transperitoneal approaches, lateral and anterior. Especially in left adrenal tumors and cases with more retroperitoneal fat, Hori et al. suggested that the combined lateral and anterior transperitoneal LA has the advantage of providing a sufficient surgical field and anatomical orientation in a timely manner, and that the combined approach allowed easy and early ligation of the drainage vein which was the source of the catecholamines.

When surgeons believe that the left adrenal tumor might be producing a large amount of CEA, Dr. Hori and colleagues recommend that investigators perform selective venography and direct blood sampling of the drainage vein of the tumor for verification, as this method was useful for detecting the source of CEA.


'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. Nourishment Is Essential to a Youthful Appearance. Time to Feed Your Face with Serum_G
2. Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia
3. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
4. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
5. Planet Technologies Announces Completion of Antigen Laboratories Acquisition
6. Adult offspring of parents with PTSD have lower cortisol levels
7. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
8. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
9. Cleveland-based Health Care Tech Company Within3 Names New CEO
10. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... In its newly released Infusion Therapy ... should be used to ensure patient safety when placing an IV catheter. A ... the use of vein visualization technology in patients with difficult venous access or ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi ... Management Solution Providers list for its expertise in eClinical Solutions. DDi has built ... serve the technology needs of global clients. DDi provides smarter technology for Clinical ...
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... PA (PRWEB) , ... February 12, 2016 , ... Each ... event will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 ... can see new therapy products in action, learn more about their chosen field and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... at Zuckerberg San Francisco General Hospital on April 5-7. The series is a ... create new habits. The workshops cover a broad range of topics, including coaching ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a ... and medical practitioners, announced today the recent launching of ... visitors a variety of features that enhance the user ... surgery supplies. --> ... a fairly new company that started in early 2016, ...
(Date:2/11/2016)... 2016 - Cardiac Marker ... Medicine and Cancer Therapy. - European Point of ... Markets. - Key Diagnostic Testing Markets. - ... in Genetic Testing. - Molecular Diagnostics in Infectious ... Over-the-Counter Diagnostic Products World Markets. - Point of ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology: